HomeACBM • OTCMKTS
add
ACRO Biomedical Co Ltd
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.61K | 49.83% |
Net income | -15.56K | -53.43% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.00 | -97.19% |
Total assets | 53.28K | 17.66% |
Total liabilities | 370.80K | 15.27% |
Total equity | -317.52K | — |
Shares outstanding | 60.04M | — |
Price to book | -0.07 | — |
Return on assets | -86.77% | — |
Return on capital | 34.00% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -15.56K | -53.43% |
Cash from operations | -93.98K | -1,384.97% |
Cash from investing | — | — |
Cash from financing | 93.76K | 1,219.81% |
Net change in cash | -225.00 | -129.03% |
Free cash flow | -92.41K | -1,467.08% |
About
Founded
2014
Headquarters
Website
